Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73.5Revenue (TTM) $M22.9Net Margin (%)-56.5Altman Z-Score-52.0
Enterprise Value $M135EPS (TTM) $-0.1Operating Margin %-10.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score-7.0Pre-tax Margin (%)-61.7Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.1Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %-24.6Current Ratio0.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-100.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M161ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NAVB is held by these investors:



NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-12-01Sell12,500$1.5-69.33view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-11-02Sell12,500$1.98-76.77view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-10-01Sell12,500$2.27-79.74view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.88-75.53view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.71-73.1view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.24-62.9view
Troup Gordon ADirector 2015-05-29Buy10,000$1.31-64.89view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.31-64.89view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.33-65.41view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-70.89view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 

More From Other Websites
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Feb 16 2017
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 10 2017
Navidea to Hold Conference Call to Provide Investor Update on Status of Ongoing Corporate Events Jan 27 2017
Navidea to Present at Upcoming Investor Conference Jan 06 2017
Navidea to Present at Upcoming Investor Conference Jan 06 2017
ETFs with exposure to Navidea Biopharmaceuticals, Inc. : December 29, 2016 Dec 29 2016
ETFs with exposure to Navidea Biopharmaceuticals, Inc. : December 13, 2016 Dec 13 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 30 2016
Edited Transcript of NAVB earnings conference call or presentation 3-Nov-16 12:30pm GMT Nov 28 2016
ETFs with exposure to Navidea Biopharmaceuticals, Inc. : November 28, 2016 Nov 28 2016
Navidea Signs Asset Purchase Agreement with Cardinal Health Nov 23 2016
Navidea Signs Asset Purchase Agreement with Cardinal Health Nov 23 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Financials Nov 17 2016
Navidea Biopharmace21860helestones Nov 14 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : November 8, 2016 Nov 08 2016
Navidea Biopharmaceuticals, Inc. :NAVB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7,... Nov 07 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 03 2016
Navidea Reports 2016 Third Quarter Financial Results Nov 03 2016
Navidea Reports 2016 Third Quarter Financial Results Nov 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)